Alexandria Real Estate Equities
ARE
#2516
Rank
A$10.00 B
Marketcap
A$57.42
Share price
2.17%
Change (1 day)
-48.67%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -A$1.48 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.94 Billion. a decrease over its 2024 earnings that were of A$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -A$1.38 Billion-242.13%
2024 A$0.96 B96.11%
2023 A$0.49 B-53.56%
2022 A$1.06 B-3.96%
2021 A$1.10 B-20.26%
2020 A$1.38 B72.88%
2019 A$0.80 B3.11%
2018 A$0.77 B73.54%
2017 A$0.44 B464.88%
2016 A$79.28 M-77.32%
2015 A$0.34 B36.31%
2014 A$0.25 B-10.81%
2013 A$0.28 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.13 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.69 B-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.45 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.59 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.64 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.94 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.79 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA